Literature DB >> 16099806

Inflammatory biomarkers predict relapse in IBD.

P Hanaway, A Roseth.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16099806      PMCID： PMC1774635          DOI： 10.1136/gut.2005.070615

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  10 in total

1.  Improved assay for fecal calprotectin.

Authors:  H Tøn; S Dale; J Holtlund; E Skuibina; H Schjønsby; B Johne
Journal:  Clin Chim Acta       Date:  2000-02-25       Impact factor: 3.786

2.  Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease.

Authors:  W J Sandborn; E V Loftus; J F Colombel; K A Fleming; F Seibold; H A Homburger; B Sendid; R W Chapman; W J Tremaine; D K Kaul; J Wallace; W S Harmsen; A R Zinsmeister; S R Targan
Journal:  Inflamm Bowel Dis       Date:  2001-08       Impact factor: 5.325

3.  Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study.

Authors:  A G Røseth; M K Fagerhol; E Aadland; H Schjønsby
Journal:  Scand J Gastroenterol       Date:  1992-09       Impact factor: 2.423

Review 4.  Technology insight: calprotectin, lactoferrin and nitric oxide as novel markers of inflammatory bowel disease.

Authors:  Jon O Lundberg; Per M Hellström; Magne K Fagerhol; Eddie Weitzberg; Arne G Roseth
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2005-02

5.  A survey of methodological variation in the Crohn's disease activity index.

Authors:  Bruce E Sands; Choon Jin Ooi
Journal:  Inflamm Bowel Dis       Date:  2005-02       Impact factor: 5.325

6.  Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease.

Authors:  A G Røseth; E Aadland; K Grzyb
Journal:  Scand J Gastroenterol       Date:  2004-10       Impact factor: 2.423

7.  Clinical remission in Crohn's disease--assessment using faecal 111In granulocyte excretion.

Authors:  S H Saverymuttu
Journal:  Digestion       Date:  1986       Impact factor: 3.216

8.  A simple method for assessing intestinal inflammation in Crohn's disease.

Authors:  J Tibble; K Teahon; B Thjodleifsson; A Roseth; G Sigthorsson; S Bridger; R Foster; R Sherwood; M Fagerhol; I Bjarnason
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

9.  Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease.

Authors:  J A Tibble; G Sigthorsson; S Bridger; M K Fagerhol; I Bjarnason
Journal:  Gastroenterology       Date:  2000-07       Impact factor: 22.682

10.  Faecal calprotectin: a new marker for Crohn's disease?

Authors:  Julie Wassell; Sunil Dolwani; Magda Metzner; H Losty; Anthony Hawthorne
Journal:  Ann Clin Biochem       Date:  2004-05       Impact factor: 2.057
  10 in total
  1 in total

Review 1.  The Value of Fecal Markers in Predicting Relapse in Inflammatory Bowel Diseases.

Authors:  Bianca J Galgut; Daniel A Lemberg; Andrew S Day; Steven T Leach
Journal:  Front Pediatr       Date:  2018-01-19       Impact factor: 3.418
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.